Second-line FOLFOX chemotherapy for advanced biliary tract cancer

被引：0
|
作者：
Brandi, Giovanni [1 ,2 ]
Frega, Giorgio [1 ,2 ]
Rizzo, Alessandro [1 ,2 ]
机构：
[1] S Orsola Malpighi Univ Hosp, Dept Expt Diagnost & Specialty Med, I-40138 Bologna, Italy
[2] IRCCS Azienda Osped Univ Bologna, Med Oncol, Bologna, Italy
来源：
LANCET ONCOLOGY | 2021年 / 22卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E285 / E285
页数：1
相关论文
共 50 条
  • [1] Second-line chemotherapy in patients with advanced biliary tract cancer
    Takahara, Naminatsu
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Ishigaki, Kazunaga
    Saito, Kei
    Mizuno, Suguru
    Kogure, Hirofumi
    Tada, Minoru
    Koike, Kazuhiko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Benefit of second-line chemotherapy for advanced biliary tract cancer.
    Moik, Florian
    Riedl, Jakob M.
    Winder, Thomas
    Bezan, Angelika
    Rossmann, Christopher
    Szkandera, Joanna
    Kasparek, Anne-Katrin
    Schaberl-Moser, Renate
    Pichler, Martin
    Stoger, Herbert
    Stotz, Michael
    Gerger, Armin
    Posch, Florian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES
    Brungs, Daniel
    Aghmesheh, Morteza
    Sjoquist, Katrin
    Goldstein, David
    [J]. Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 168 - 168
  • [4] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Second-line chemotherapy in advanced biliary tract cancer: Who may benefit?
    Salati, Massimiliano
    Caputo, Francesco
    Marcheselli, Luigi
    Rimini, Margherita
    Spallanzani, Andrea
    Gelsomino, Fabio
    Andrikou, Kalliopi
    Zironi, Sandra
    Di Emidio, Katia
    Clo', Vera
    Luppi, Gabriele
    Cascinu, Stefano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [6] Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey
    Vasile, E.
    Di Girolamo, S.
    Cereda, S.
    Lonardi, S.
    Leone, F.
    Russano, M.
    Silvestris, N.
    Vivaldi, C.
    Fornaro, L.
    Brandi, G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S614 - S614
  • [7] Capecitabine and cisplatin as a second-line chemotherapy for patients with advanced biliary tract cancer
    Shin, Kabsoo
    Lee, In Seok
    Hong, Tae Ho
    Kim, Joori
    Lee, Myung Ah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] Outcome of second-line chemotherapy for biliary tract cancer
    Bridgewater, John
    Palmer, Daniel
    Cunningham, David
    Iveson, Tim
    Gillmore, Roopinder
    Waters, Justin
    Harrison, Mark
    Wasan, Harpreet
    Corrie, Pippa
    Valle, Juan
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1511 - 1511
  • [9] Combination therapy with capecitabine and cisplatin as second-line chemotherapy for advanced biliary tract cancer
    Jung, Jang Han
    Chung, Moon Jae
    Bang, Seungmin
    Park, Seung Woo
    Song, Si Young
    Park, Jeong Youp
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 210 - 210
  • [10] Feasibility and potential benefits of second-line chemotherapy in patients with advanced biliary tract cancer
    Walter, Thomas
    Horgan, Anne M.
    McKeever, Elizabeth
    Min, Trisha
    McNamara, Mairead
    Hedley, David W.
    Serra, Stefano
    Krzyzanowska, Monika K.
    Chen, Eric Xueyu
    Mackay, Helen
    Feld, Ronald
    Moore, Malcolm J.
    Knox, Jennifer J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345